HU9201659D0 - Non-replicating recombinant retrovirus particles and anti-virus and immunogene preparations - Google Patents

Non-replicating recombinant retrovirus particles and anti-virus and immunogene preparations

Info

Publication number
HU9201659D0
HU9201659D0 HU9201659A HU165990A HU9201659D0 HU 9201659 D0 HU9201659 D0 HU 9201659D0 HU 9201659 A HU9201659 A HU 9201659A HU 165990 A HU165990 A HU 165990A HU 9201659 D0 HU9201659 D0 HU 9201659D0
Authority
HU
Hungary
Prior art keywords
immunogene
virus
preparations
recombinant retrovirus
replicating recombinant
Prior art date
Application number
HU9201659A
Other languages
Hungarian (hu)
Other versions
HUT60506A (en
Inventor
Omar K Haffar
Shiu-Lok Hu
Allen W Senear
Bruce M Travis
Original Assignee
Oncogen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncogen filed Critical Oncogen
Publication of HU9201659D0 publication Critical patent/HU9201659D0/en
Publication of HUT60506A publication Critical patent/HUT60506A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Analytical Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HU9201659A 1989-11-20 1990-11-20 Process for producing non-replicable, recombinant retrovirus particles and antiviral and immunogenic preparations HUT60506A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US43920589A 1989-11-20 1989-11-20

Publications (2)

Publication Number Publication Date
HU9201659D0 true HU9201659D0 (en) 1992-08-28
HUT60506A HUT60506A (en) 1992-09-28

Family

ID=23743729

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9201659A HUT60506A (en) 1989-11-20 1990-11-20 Process for producing non-replicable, recombinant retrovirus particles and antiviral and immunogenic preparations

Country Status (14)

Country Link
EP (1) EP0502105A4 (en)
JP (1) JPH05503629A (en)
KR (1) KR920703639A (en)
AU (1) AU636944B2 (en)
CA (1) CA2068713A1 (en)
ES (1) ES2052478T1 (en)
FI (1) FI922277A (en)
GR (1) GR930300005T1 (en)
HU (1) HUT60506A (en)
NO (1) NO921969L (en)
OA (1) OA09698A (en)
TW (1) TW216446B (en)
WO (1) WO1991007425A1 (en)
ZA (1) ZA909302B (en)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0431128B1 (en) * 1989-06-01 2003-03-26 Applied Biotechnology, Inc. Vector coding for self-assembled, defective, non-self-propagating viral particles
US5861282A (en) * 1989-10-16 1999-01-19 Whitehead Institute For Biomedical Research Non-infectious HIV particles and uses therefor
WO1991019803A1 (en) * 1990-06-19 1991-12-26 Applied Biotechnology, Incorporated Self assembled, defective, nonself-propagating viral particles
DE4124817A1 (en) * 1991-07-26 1993-01-28 Basf Ag AQUEOUS POLYMER DISPERSIONS
DK0611397T3 (en) * 1991-11-08 2002-10-07 Upjohn Co Vaccine against cat leukemia virus
CA2118026A1 (en) * 1992-04-14 1993-10-28 Guy T. Layton Induction of ctl responses
DK1473369T3 (en) 1993-01-26 2009-03-09 Univ Pennsylvania Preparations and methods for administering genetic material
DE69434469T2 (en) 1993-01-26 2006-06-14 Univ Pennsylvania COMPOSITIONS AND METHOD FOR THE ADMINISTRATION OF GENETIC MATERIAL
US7001759B1 (en) 1993-01-26 2006-02-21 The Trustees Of The University Of Pennsylvania Compositions and methods for delivery of genetic material
GB9304239D0 (en) * 1993-03-01 1993-04-21 British Bio Technology Viral particles
US5955342A (en) * 1994-08-15 1999-09-21 Connaught Laboratories Limited Non-infectious, replication-defective, self-assembling HIV-1 viral particles containing antigenic markers in the gag coding region
US6291157B1 (en) 1998-02-23 2001-09-18 Connaught Laboratories Limited Antigenically-marked non-infectious retrovirus-like particles
US5858838A (en) 1998-02-23 1999-01-12 Taiwan Semiconductor Manufacturing Company, Ltd. Method for increasing DRAM capacitance via use of a roughened surface bottom capacitor plate
US6080408A (en) 1994-08-22 2000-06-27 Connaught Laboratories Limited Human immunodeficiency virus type 1 nucleic acids devoid of long terminal repeats capable of encoding for non-infectious, immunogenic, retrovirus-like particles
CN1185811A (en) * 1995-03-31 1998-06-24 H·沃尔夫 Antigen presentation system on retrovirus-like particles
US6013506A (en) * 1995-06-05 2000-01-11 Wardley; Richard C. Feline leukemia virus vaccines
US6121021A (en) * 1997-12-16 2000-09-19 Connaught Laboratories Limited Constitutive expression of non-infectious HIV-like particles
EP1141314A2 (en) 1998-12-31 2001-10-10 Chiron Corporation Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
AU2596600A (en) 1998-12-31 2000-07-31 Chiron Corporation Modified hiv env polypeptides
WO2002072754A2 (en) * 2001-03-08 2002-09-19 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Mva expressing modified hiv envelope, gag, and pol genes
US8623379B2 (en) 2000-03-02 2014-01-07 Emory University Compositions and methods for generating an immune response
EP1418940A4 (en) 2000-03-02 2006-09-20 Univ Emory Dna expression vectors and methods of use
AU2002320314A1 (en) 2001-07-05 2003-01-21 Chiron, Corporation Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
US20030170614A1 (en) 2001-08-31 2003-09-11 Megede Jan Zur Polynucleotides encoding antigenic HIV type B polypeptides, polypeptides and uses thereof
DK2694101T3 (en) 2011-04-06 2017-01-09 Biovaxim Ltd Pharmaceutical compositions for the prevention and / or treatment of HIV disease in humans
EP4218805A1 (en) 2015-07-21 2023-08-02 ModernaTX, Inc. Infectious disease vaccines
WO2018170270A1 (en) 2017-03-15 2018-09-20 Modernatx, Inc. Varicella zoster virus (vzv) vaccine
WO2018170256A1 (en) 2017-03-15 2018-09-20 Modernatx, Inc. Herpes simplex virus vaccine
EP3938379A4 (en) * 2019-03-15 2023-02-22 ModernaTX, Inc. Hiv rna vaccines

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4752565A (en) * 1986-04-07 1988-06-21 The United States Of America As Represented By The Department Of Health And Human Services Cell line producing AIDS viral antigens without producing infectious virus particles
JPH02203783A (en) * 1989-02-02 1990-08-13 Banyu Pharmaceut Co Ltd Cloned human t cell forming non-virulent aids virus having antigenicity
JP3140757B2 (en) * 1989-02-06 2001-03-05 デイナ・フアーバー・キヤンサー・インステイテユート Packaging defective HIV provirus, cell lines and uses thereof
GB8923123D0 (en) * 1989-10-13 1989-11-29 Connaught Lab A vaccine for human immunodeficiency virus
WO1991005860A1 (en) * 1989-10-16 1991-05-02 Whitehead Institute For Biomedical Research Non-infectious hiv-1 particles and uses therefor

Also Published As

Publication number Publication date
EP0502105A4 (en) 1993-02-24
JPH05503629A (en) 1993-06-17
OA09698A (en) 1993-08-30
GR930300005T1 (en) 1993-04-28
CA2068713A1 (en) 1991-05-21
KR920703639A (en) 1992-12-18
ZA909302B (en) 1991-09-25
HUT60506A (en) 1992-09-28
EP0502105A1 (en) 1992-09-09
NO921969D0 (en) 1992-05-19
TW216446B (en) 1993-11-21
FI922277A0 (en) 1992-05-19
ES2052478T1 (en) 1994-07-16
NO921969L (en) 1992-06-26
AU6905591A (en) 1991-06-13
WO1991007425A1 (en) 1991-05-30
AU636944B2 (en) 1993-05-13
FI922277A (en) 1992-05-19

Similar Documents

Publication Publication Date Title
HU9201659D0 (en) Non-replicating recombinant retrovirus particles and anti-virus and immunogene preparations
GB2245272B (en) Recombinant virus selection system
GB2181435B (en) Recombinant lav/htlv virus and vaccines
AR241939A1 (en) Recombinant avipox virus
AU7565694A (en) Methods and compositions for the large scale production of recombinant adeno-associated virus
IL94243A0 (en) Fusion polypeptide and its preparation
AU585180B2 (en) Nor-statine and nor-cyclostatine polypeptides
IL112860A0 (en) Recombinant viruses their preparation and their therapeutic uses
GB8821528D0 (en) Recombinant vaccinia virus
HUT58371A (en) Recombinant virus of marek-disease
EP0491844A4 (en) Peptides including ctl epitopes of hiv proteins and use thereof
AU1648092A (en) Defective recombinant adenoviruses expressing characteristic epstein-barr virus proteins
AU633294B2 (en) Motilin-like polypeptide and use thereof
IL92504A0 (en) Recombinant proteins with adipsin and complement d activities
EP0696204A4 (en) Recombinant fowlpox viruses and uses thereof
AU634773B2 (en) Spheroidin dna isolate and recombinant entomopoxvirus expression vectors
EP0525828A3 (en) Recombinant polypeptides and their uses, including assay for aids virus
EP0404835A4 (en) Novel recombinant vaccinia virus expression vectors and method of selecting same
ZA946887B (en) Novel proteins/polypeptides and cotransfection plasmics and live recombinant carriers therefor
IL79880A0 (en) Recombinant virus
IL90772A0 (en) Sialic acid-bonded octapeptide and preparation thereof
AU4824090A (en) Promoter, plasmid containing the same, and recombinant avipoxvirus
KR970009290B1 (en) Recombinant dna and expression plasmid for the preparation of motilin-like peptide
AU628956B2 (en) New polypeptide and antibacterial preparations containing the same
IL90553A0 (en) Protein and coding sequence for detection and differentiation of siv and hiv-2 group of viruses

Legal Events

Date Code Title Description
DFC4 Cancellation of temporary protection due to refusal